搜索临床试验以:比卡鲁胺,CP-675,206
总计934个结果
-
National Cancer Institute (NCI)NRG Oncology主动,不招人复发性输卵管癌 | 复发性原发性腹膜癌 | 原发性腹膜高级别浆液性腺癌 | 恶性卵巢子宫内膜样瘤 | 卵巢高级别浆液性腺癌 | 铂敏感性卵巢癌 | 输卵管高级别浆液性腺癌 | 复发性输卵管子宫内膜样腺癌 | 复发性卵巢子宫内膜样腺癌 | 复发性原发性腹膜子宫内膜样腺癌 | 输卵管子宫内膜样瘤 | 铂敏感性输卵管癌 | 铂敏感原发性腹膜癌 | 复发性卵巢浆液性腺癌美国
-
AstraZeneca完全的黑色素瘤美国, 意大利, 西班牙, 瑞典, 比利时, 加拿大, 波兰, 瑞士, 法国, 俄罗斯联邦, 英国, 澳大利亚, 阿根廷, 德国, 荷兰, 以色列, 南非, 奥地利, 希腊, 墨西哥, 斯洛伐克
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)完全的
-
Kyowa Kirin, Inc.AstraZeneca完全的
-
Pfizer终止
-
Institute for Clinical and Experimental Medicine招聘中
-
University of California, San FranciscoCalifornia Breast Cancer Research Program完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...AstraZeneca主动,不招人
-
Mayo ClinicNational Cancer Institute (NCI)招聘中III 期肝内胆管癌 AJCC v8 | IV 期肝内胆管癌 AJCC v8 | 不可切除的肝内胆管癌 | 局部晚期肝内胆管癌 | 少转移性肝内胆管癌美国
-
AstraZeneca主动,不招人
-
Abramson Cancer Center of the University of Pennsylvania完全的
-
Abramson Cancer Center of the University of Pennsylvania完全的
-
Astellas Pharma IncOSI Pharmaceuticals完全的
-
Astellas Pharma IncOSI Pharmaceuticals; Cell Pathways完全的
-
University of Colorado, DenverNational Cancer Institute (NCI)招聘中
-
Azienda Usl di BolognaMinistero della Salute, Italy招聘中
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)未知
-
Astellas Pharma IncOSI Pharmaceuticals; Cell Pathways终止
-
The University of Texas Health Science Center at...Massachusetts General Hospital; 59th Medical Wing; Uniformed Services University of the Health... 和其他合作者招聘中
-
Kaiser PermanenteNorthwestern University; Duke University; Essentia Health; Georgia State University主动,不招人
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); Hamilton Academic Health Sciences Organization完全的
-
University of LeipzigJena University Hospital招聘中
-
Yale UniversityNational Center for Complementary and Integrative Health (NCCIH)主动,不招人